Jeffrey Ryan Stewart is CCO & VP at AbbVie Inc. (ABBV). They have made 10 open-market trades across 1 company since 2019, most recently 2026-02-27.
CIK 0001761675
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2019, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABBV | 83,171 | $23.7M |
Shares reported on the most recent Form 4, priced at the 2026-03-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL | 2025-03-31 | 2025-04-02 | $210.25 | $19.3M | -14.8% | -5.6% | -9.7% |
| ABBV | SELL | 2024-03-18 | 2024-03-20 | $178.79 | $21.1M | +2.2% | -5.9% | -3.1% |
| ABBV | SELL | 2023-03-13 | 2023-03-15 | $152.28 | $16.2M | +2.8% | +5.5% | -9.7% |
| ABBV | SELL | 2022-03-24 | 2022-03-25 | $159.20 | $4.4M | +5.2% | -2.7% | -6.9% |
| ABBV | SELL | 2022-03-01 | 2022-03-01 | $148.20 | $6.0M | +0.9% | +9.8% | -0.2% |
| ABBV | SELL | 2021-12-15 | 2021-12-17 | $128.00 | $275K | +5.8% | +6.4% | +23.4% |
| ABBV | SELL | 2021-03-01 | 2021-03-02 | $108.59 | $3.0M | +1.3% | +1.6% | +5.0% |
| ABBV | SELL | 2020-12-29 | 2020-12-31 | $105.00 | $2.7M | +4.9% | -4.5% | +1.0% |
| ABBV | SELL | 2020-05-12 | 2020-05-12 | $90.00 | $2.1M | +1.5% | +1.7% | +1.8% |
| ABBV | BUY | 2019-08-16 | 2019-08-20 | $64.44 | $2.0M | -2.4% | +6.4% | +31.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.